Philip Morris International is trading 3% down at $181.44 as investors lock in profits and weigh valuation concerns following a significant rally.
- The recent surge was fueled by optimism surrounding the FDA’s modified-risk tobacco product (MRTP) approval for 20 ZYN nicotine pouch variants and positive analyst adjustments.
- Despite strong momentum in the company's smoke-free product segment, some analysts have recently trimmed fair-value estimates and price targets.
- Today's pullback reflects a cooling period after the sharp run-up driven by the regulatory milestone and previous price-target upgrades.